Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0000902664-25-002323·Matrix Capital Management Company, LP
Schedule 13G ownership disclosure
Maze Therapeutics Inc
Common Stock, $0.001 par value per share · CUSIP: 578784100
Event date: 2025-03-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Matrix Capital Management Company, LP
Shares: 2,486,184.00 · Class: 5.7%
- David E. Goel
Shares: 2,486,184.00 · Class: 5.7%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902664-25-002323
- Form type
- SCHEDULE 13G
- Filer
- Matrix Capital Management Company, LP
- CIK
- CIK 1410830
- Filed
- May 14, 2025
- Reporting period
- Mar 31, 2025
- Description
- Schedule 13G beneficial ownership